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Abstract
Background: Research has shown that mobile phone contraceptive behavioral interventions can increase knowledge
and use of contraception, but other studies have failed to demonstrate a beneficial effect. The objective of this trial was
to estimate the effect of a contraceptive behavioral intervention delivered by mobile phone text message on young
Palestinian women’s attitudes towards effective contraception.
Methods: We conducted a randomized controlled trial among women aged 18–24 years living in the West Bank, who
were not using an effective method of contraception. The intervention group received zero to three messages per day
(113 messages for female-not married and 120 messages for female-married) for 120 days. The control group received
16 messages over 120 days about trial participation. The primary outcome was acceptability of at least one method of
effective contraception at 4 months. Secondary outcomes were use of effective contraception at 4 months and any
use during the study, acceptability of individual methods, service uptake, unintended pregnancy and abortion. Process
outcomes included knowledge, perceived norms, personal agency and intention. All outcomes were self-reported. We
analyzed the outcomes using logistic and linear regression.
Results: A total of 578 participants were enrolled and 464 (80%) completed follow up at 4 months. Intervention group
participants were more likely to find at least one method of effective contraception acceptable (31% in the
intervention group versus 17% in the control group, adjusted OR 2.34, 95% CI 1.48–3.68, p < 0.001). They had a higher
mean knowledge score, were more likely to find the intrauterine device, injection, implant and patch acceptable, to
agree that their friends would use an effective method and to intend to use an effective method, compared to
participants in the control group. While in the direction of intervention benefit, there were no differences between the
groups in the use of effective contraception at 4 months and any use during the study, pill acceptability, service
uptake, unintended pregnancy and induced abortion.
Conclusions: The intervention can improve attitudes, knowledge-perceived norms and intention to use effective
contraception among young women in Palestine. Research is needed to evaluate the efficacy of the intervention for
contraceptive behavioral outcomes in Palestine.
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Background
Unintended pregnancy continues to be a global health
problem [1]. Women with an unmet need of modern
contraception account for an estimated 84% of all unin-
tended pregnancies in developing regions [2]. Satisfying
unmet need of modern contraception is essential in
avoiding unintended pregnancies, and identifying the
barriers that prevent people from using contraceptive
methods can help achieve this [3, 4].
Sexual and reproductive health in the State of
Palestine (the West Bank, East Jerusalem and the Gaza
Strip, hereafter referred to as “Palestine”) has been nega-
tively affected by the conflict [5, 6]. It is estimated that
38% of pregnancies are unintended [7], with the unmet
need of contraception peaking at 15% among women
aged 20–24 years [8]. While the adolescent fertility rate
has decreased substantially over the past 20 years, the
current adolescent fertility rate of 48 per 1000 women
aged 15–19 years remains higher than in most other
countries in the region [8, 9]. The Palestinian Family
Survey 2010 found that among married women not
using contraception and not reporting wanting to have a
child, the main reasons given for not using contracep-
tion were fear of side effects, the inconvenience of the
contraceptive methods and their husband’s opposition
[10, 11].
Mobile phones are commonly used to deliver health
behavioral support [12–18]. In Palestine, delivering
contraceptive support by mobile phone may be an ad-
vantageous mode by which to reach people in the sub-
stantial area that is underserved with regard to sexual
and reproductive health services [19]. There is some evi-
dence from trials that interventions delivered by mobile
phone can improve contraceptive use [20–22] and
knowledge [20, 23–25]; however, other trials have not
found a beneficial effect [26–30].
The London School of Hygiene and Tropical Medicine
(LSHTM) and the Palestinian Family Planning and Pro-
tection Association (PFPPA) developed a contraceptive
behavioral intervention in Palestine, which is delivered
by mobile phone [31]. This paper reports the results of
the evaluation of the intervention.
Methods
The methods are summarized in this section. Detailed
methods are published in the trial protocol [32] and the
statistical analysis plan [33].
Aim, study design and participants
This was a parallel group, individually randomized trial
with a 1:1 allocation ratio. The aim was to assess the ef-
fect of the intervention on attitudes towards the
non-permanent effective contraceptive methods [34–36]
available in Palestine (oral contraceptive pills (OCs),
intrauterine devices (IUDs), injectables, implants and the
patch). Women were eligible to take part if they were
between 18 and 24 years of age, did not report using an
effective method of contraception, owned a personal
mobile phone, lived in the West Bank and could read
Arabic. The trial was promoted through PFPPA’s service
delivery points and outreach sites, the PFPPA website
and the distribution of trial promotional material via
flyers and social media sites. We recruited participants
through PFPPA’s service delivery points and outreach
sites in Jerusalem, Bethlehem, Halhoul and Ramallah.
Intervention and control
The intervention was informed by the integrated behav-
ioral model [37] and was sent by mobile phone text mes-
sage. It was tailored according to marital status,
resulting in two sets of intervention messages: (1)
female-married and (2) female-not married. Most of the
messages in the two sets overlap, with minor tailoring so
that the messages are relevant to marital status (marital
status was used as a proxy for sexual activity because in
this context it was thought inappropriate to ask about
sexual activity if not married). Participants allocated to
the intervention group received zero to three messages
per day (113 messages for female-not married and 120
messages for female-married) for 120 days.
The intervention messages provided information about
contraception, targeted beliefs identified in the develop-
ment phase that influence contraceptive use (e.g. mis-
conceptions about the side effects and health risks of
contraception, belief that non-hormonal methods are
better because they are not harmful to health) and aimed
to support young women in believing that they can in-
fluence their reproductive health. The intervention con-
tained the following behavior change methods, adapted
for delivery by mobile phone [38]: belief selection, facili-
tation, anticipated regret, guided practice, verbal persua-
sion, tailoring, cultural similarity, arguments, shifting
perspective and goal setting.
Participants allocated to the control group received 16
control messages about trial participation over 120 days.
McCarthy et al. Trials          (2019) 20:228 Page 2 of 13
Details on the development of the intervention can be
found in the intervention development publication [31]
and the trial protocol [32].
Allocation and intervention delivery
The online trial database and randomization system
were used to generate the allocation sequence, and
randomization occurred immediately after the baseline
data were submitted by the clinic research staff. The sys-
tem sent the Palestinian texting platform the allocation,
preferred time slot for message delivery, mobile phone
number and marital status.
Protecting against bias
Participants would have been aware of the allocation
after they started receiving the messages. Allocation was
masked from the research staff collecting outcome data
unless the participant revealed it to them. Treatment al-
location was masked from the researchers who analyzed
the data.
Outcomes
Primary outcome
The primary outcome was the proportion of participants
reporting that at least one method of effective contra-
ception was acceptable at 4 months post randomization.
The acceptability of each method was measured by the
following stems: Using the [method] … causes infertility,
… causes unwanted side effects, … is easy, … is a good
way to prevent pregnancy and I would recommend the
[method] to a friend. The IUD and implant included an
additional stem: The [method] insertion would not be a
problem for me. The response options for each stem
were: strongly disagree, disagree, not sure, agree,
strongly agree and I do not know what the [method] is.
A method was acceptable if participants reported agree
or strongly agree for all stems except for … causes infer-
tility and … causes unwanted side effects, for which dis-
agree or strongly disagree indicated acceptability [32].
Secondary outcomes
Secondary outcomes were the use of effective contracep-
tion at 4 months and any use during the study, the ac-
ceptability of individual methods and service uptake,
unintended pregnancy and abortion.
Process outcomes The process outcomes were know-
ledge of effective contraception; perceived norms and
personal agency in relation to using and communicating
with partners about contraception and intention to use
effective contraception and intervention dose received.
Data collection
All outcomes were self-reported. At baseline, we col-
lected personal and demographic data and the primary
outcome data via self-completed paper questionnaire.
We collected data on all outcomes at 4-month follow
up. Staff, masked to treatment allocation, collected the
follow-up data verbally by telephone.
Sample size
The trial was powered to detect a 15% absolute increase
in the acceptability (corresponding to an odds ratio (OR)
of 1.86) of effective contraception in the intervention
group compared to the control group. A sample of 454
participants would provide 90% power to detect a 15%
absolute increase in acceptability, at the 5% significance
level, assuming 50% acceptability in the control group.
We allowed for 20% loss to follow up and aimed to
randomize 570 participants.
Statistical analysis
The trial protocol was accepted for publication on 14
September 2017 [32] and the detailed statistical analysis
plan was publicly released before conducting the data
analysis, on 7 November 2017 [33]. Analyses were con-
ducted according to randomized group and only partici-
pants with complete outcome data were included in the
principal analysis. All statistical tests were two-sided and
considered significant at the 5% level. The analysis was
conducted using Stata 15. Unmasking occurred on 6
February 2018, after the masked data were analyzed as
outlined within the analysis plan.
Loss to follow up and missing data
We used the chi-squared test to investigate whether loss
to follow up differed by trial arm. We used logistic re-
gression to compare baseline characteristics of partici-
pants who completed follow up with participants who
did not. We investigated whether predictors of loss to
follow up differed by trial arm by testing for an
interaction.
Principal analysis
Analysis of the primary outcome We used logistic re-
gression to compare the proportion of participants in
each trial arm who reported that at least one method of
contraception was acceptable. We report the crude and
adjusted OR with the 95% confidence interval (CI) and p
value. We adjusted the primary analysis regression for
prespecified baseline covariates [32, 33].
Analysis of the secondary outcomes The analysis of
the secondary outcomes was similar to the analysis of
the primary outcome, although in analysis of the
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acceptability of the individual methods, the acceptability
of that method at baseline replaced the acceptability of
at least one method at baseline as a covariate.
Analysis of the process outcomes The process out-
comes of perceived norms, personal agency and
intention each comprised ordinal scales. Each scale was
analyzed individually using ordered logistic regression.
For knowledge, we used linear regression to assess the
difference in the mean scores between the groups. To
quantify the “dose” of the intervention that the interven-
tion participants received, we analyzed the number of
messages that participants reported to have read (all,
most, some, none) and whether they stopped the mes-
sages, along with our monitoring data.
Additional analyses
Sensitivity analyses We conducted two sensitivity ana-
lyses to account for missing data. In the first, we consid-
ered that all participants who were lost to follow up did
not find at least one method acceptable. In the second,
we adjusted for the main baseline predictors of missing-
ness. Both sensitivity analyses were adjusted for the
baseline covariates as aforementioned.
Subgroup analysis We conducted an exploratory sub-
group analysis for the primary outcome with prespeci-
fied subgroups [33]. Within the subgroups, we assessed
the heterogeneity of the estimated treatment effect with
a test for interaction [39, 40]. We estimated ORs with
95% CIs for each subgroup.
Contamination We report the proportion of control
group participants who reported that they read another
participant’s messages and the proportion of interven-
tion participants that reported that their messages were
read by another participant.
Report of physical violence We report the proportion
of participants in each group that reported experiencing
physical violence during the study.
Results
Recruitment, randomization, exclusions
Between 8 December 2016 and 22 July 2017, 586 ran-
domizations were performed by the system. During the
trial follow-up we discovered that four of the partici-
pants enrolled were randomized twice. The two partici-
pants who were allocated to the same group on both
randomizations were kept in the trial, using the baseline
data from their first record (the system allowed only one
follow-up record). We excluded the two participants
who were allocated to different groups from the analysis.
In addition, one record was excluded because the par-
ticipant’s incorrect mobile number was entered onto the
database (the correct record and number was kept) and
another record was excluded because the participant
was recruited in error (the participant was using an IUD
and was therefore ineligible). This resulted in 578 partic-
ipants being included in the trial (Fig. 1).
There were 289 participants allocated to the interven-
tion group and 289 to the control group. No participants
withdrew from the trial after allocation.
Baseline characteristics
Baseline characteristics of trial participants are reported in
Table 1. Mean age was 21 years, and 71% (409/578) were
aged 20–24 years: 60% of participants were not married
(259/573) and only 8% (47/578) found at least one method
of effective contraception acceptable. The characteristics
were largely similar between the two groups; however, al-
most twice as many participants in the control group re-
ported that at least one method of effective contraception
was acceptable at baseline compared to the intervention
group (10.38% in the control versus 5.88% in the interven-
tion group; see “Discussion”).
Loss to follow up
A total of 464 participants (80%) completed the trial fol-
low up for the primary outcome (control, n = 235; inter-
vention, n = 229) (Fig. 1). Retention did not differ
between the groups (81% in the control and 79% in the
intervention group, Pearson’s chi squared test p = 0.53).
The main predictor of retention was completion of uni-
versity at enrolment (OR 1.80, 95% CI 1.18–2.73, p =
0.01). The effect of this predictor of retention did not
differ by group (interaction test p = 0.78). Detailed char-
acteristics of follow-up completers and non-completers
are reported in Additional file 1.
Outcomes
In the intervention group, 31% (71/229) reported that
at least one method of contraception was acceptable
compared to 17% (40/235) in the control group
(Table 2). Participants in the intervention group had
2.34 times the odds of finding at least one method of
effective contraception acceptable compared to partic-
ipants in the control group (adjusted OR 2.34, 95%
CI 1.48–3.68, p < 0.001; crude OR 2.19, 95% CI 1.41–
3.40, p < 0.001; absolute risk difference = 14%, 95% CI
0.06-0.22, p < 0.001). The odds of participants having
an IUD, injection, implant, patch or long-acting re-
versible contraception (LARC) method were greater
in the intervention group compared to the control
group and were statistically significant (Table 3). The
odds of using effective contraception was also greater
in the intervention group; however, this could likely
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have occurred by chance (Table 2). Participants in the
intervention group had a higher mean knowledge
score, were more likely to agree that their friends
would use an effective contraceptive method and were
more likely to respond that they intend to use an ef-
fective method compared to participants in the con-
trol group (Table 3).
Additional trial data
Of the control participants, 17% (39/235) said that they
read the messages of someone else in the study; 17%
(40/229) of intervention participants said that someone
else in the study read their messages. In the intervention
group, 0.87% (2/229) reported that they experienced
physical violence during the study versus 2.13% (5/235)
Fig. 1 Consolidated standards of reporting trials (CONSORT) diagram
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Table 1 Baseline characteristics
Control
N = 289, %(n)
Intervention
N = 289, %(n)
All participants
N = 578, %(n)
Age, years
mean (sd) 21.4 (1.77) 21.2 (1.75) 21.3 (1.76)
18–19 25.9 (75) 32.5 (94) 29.2 (169)
20–24 74.0. (214) 67.5 (195) 70.8 (409)
Marital status
married 40.5 (117) 38.8 (112) 39.6 (229)
not-married 59.5 (172) 61.3 (177) 60.4 (349)
Number of children
0 72.3 (209) 79.6 (230) 75 (439)
1 16.3 (47) 10.7 (31) 13.5 (78)
2 or more 11.4 (33) 9.7 (28) 10.6 (61)
Residence
city 46.7 (135) 47.8 (138) 47.2 (273)
village 48.1 (139) 46.7 (135) 47.4 (274)
camp 4.2 (12) 4.8 (14) 4.5 (26)
Bedouin community 1 (3) 0.7 (2) 0.9 (5)
Occupation
schoola 1.7 (5) 0.4 (1) 1.0 (6)
university 48.4 (140) 52.6 (152) 44.6 (258)
working 5.2 (15) 3.5 (10) 4.3 (25)
training 14.9 (43) 15.9 (46) 15.2 (88)
parent 22.5 (65) 20.1 (58) 20.6 (119)
not working 5.9 (17) 6.6 (19) 6.2 (36)
university and working 0.4 (1) 0.4 (1) 0.4 (2)
university and parent 0.7 (2) – 0.4 (2)
school and parent 0.4 (1) 0.4 (1) 0.4 (2)
working, training and parent – 0.4 (1) 0.2 (1)
Highest level of education completed
primary 0.7 (2) 0.7 (2) 0.7 (4)
secondary 22.8 (66) 21.1 (61) 22 (127)
university 66.1 (191) 66.4 (192) 66.3 (383)
technical 10.4 (30) 11.8 (34) 11.1 (64)
Current pregnancy intention
(“Do you want a pregnancy now?”)
yes 16.3 (47) 20.1 (58) 18.2 (105)
no 25.6 (74) 24.6 (71) 25.1 (145)
unsure 4.2 (12) 1.4 (4) 2.8 (16)
not marriedb 53 (156) 53 (156) 53 (312)
Baseline method
none 39.5 (114) 41.5 (120) 40.5 (234)
male condom 0.7 (2) 0.7 (2) 0.7 (4)
not marriedb 53.6 (155) 54.3 (157) 53 (312)
calendar 1.0 (3) 0.4 (1) 0.7 (4)
LAM 3.1 (9) 1.4 (4) 2.3 (13)
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Table 1 Baseline characteristics (Continued)
Control
N = 289, %(n)
Intervention
N = 289, %(n)
All participants
N = 578, %(n)
withdrawal 2.1 (6) 1.4 (4) 1.7 (10)
other – 0.4 (1) 0.2 (1)
At least one effective method is acceptable
yes 10.4 (30) 5.9 (17) 8.1 (47)
no 89.6 (259) 94.1 (272) 91.9 (531)
Pill acceptability
yes 3.8 (11) 3.1 (9) 3.5 (20)
no 96.2 (278) 96.9 (280) 96.5 (558)
IUD acceptability
yes 4.5 (13) 1.7 (5) 3.1 (18)
no 95.5 (276) 98.3 (284) 96.9 (560)
Injection acceptability
yes 1.4 (4) 1.4 (4) 1.4 (8)
no 98.6 (285) 98.6 (285) 98.6 (570)
Implant acceptability
yes 3.1 (9) 1.7 (5) 2.4 (14)
no 96.9 (280) 98.3 (284) 97.6 (564)
Patch acceptability
yes 0.7 (2) 0.4 (1) 0.5 (3)
no 99.3 (287) 99.7 (288) 99.5 (575)
LAM lactational amenorrhea method, IUD intrauterine device
aSchool is pre-university education
bThe response “not married” was used as a proxy for sexual activity
Table 2 Primary and secondary outcomes
Control
N = 235, % (n)
Intervention
N = 229, % (n)
Adjusted OR (95% CI) p value
At least one effective method is acceptablea 17 (40) 31 (71) 2.34 (1.48–3.68);
absolute risk difference
= 14% (0.06–0.22)
< 0.001
Use of effective contraceptiona 8.5 (20) 8.7 (20) 1.42 (0.66–3.07) 0.37
Pill acceptabilityb 4.7 (11) 6.1 (14) 1.39 (0.61–3.16) 0.44
IUD acceptabilityb 6.4 (15) 14 (32) 2.76 (1.41–5.40) 0.003
Injection acceptabilityb 1.7 (4) 5.7 (13) 3.16 (0.99–10.08) 0.05
Implant acceptabilityb 5.5 (13) 11.8 (27) 2.46 (1.19–5.07) 0.02
Patch acceptabilityb 2.6 (6) 10 (23) 4.17 (1.63–10.64) 0.003
LARC acceptabilityb 11.9 (28) 23.1 (53) 2.49 (1.48–4.18) 0.001
Any effective contraceptive use during the 4 monthsa 8.1 (19) 10 (23) 1.95 (0.90–4.25) 0.09
Service uptakea (attended a service one or more times) 37 (87) 42.8 (98) 1.38 (0.94–2.04) 0.10
Unintended pregnancya 3.1 (9/289) 2.4 (7/289) 0.75 (0.27–2.10) 0.59
Induced abortiona 2.6 (6) 1.3 (3) 0.47 (0.11–1.95) 0.30
IUD intrauterine device, LARC long-acting reversible contraception
aAdjusted for pregnancy intention, age, number of children, education level and acceptability at baseline
bAdjusted for pregnancy intention, age, number of children, education level and the corresponding method acceptability at baseline
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Table 3 Process outcomes
Control
N = 235, % (n)
Intervention
N = 229, % (n)
Proportional ORa
(95% CI), p value
Knowledge of effective contraception Mean = 2.13 (sd = 1.42) Mean = 2.63 (sd = 1.66) 0.50 b (0.22–0.78), 0.001
My friends would use the pill, IUD, injection or implant if they wanted to prevent pregnancy
strongly disagree 0.9 (2) 0.4 (1) 1.46 (1.00–2.13), 0.05
disagree 9.4 (22) 5.7 (13)
not sure 21.7 (51) 17 (39)
agree 62.1 (146) 70.7 (162)
strongly agree 6 (14) 6.1 (14)
My friends would talk to their husband about contraception if they wanted to prevent a pregnancy
strongly disagree – – 0.92 (0.63–1.34), 0.66
disagree 2.6 (6) 2.6 (6)
not sure 18.3 (43) 19.7 (45)
agree 66.4 (156) 65.9 (151)
strongly agree 12.8 (30) 11.8 (27)
If you wanted to use the pill, IUD, injection or implant, how easy would it be for you to use it?
very difficult 0.9 (2) 1.3 (3) 1.26 (0.89–1.78), 0.19
difficult 9.8 (23) 8.7 (20)
not sure 48.9 (115) 41.1 (94)
easy 35.3 (83) 46.3 (106)
very easy 5.1 (12) 2.6 (6)
If you wanted to talk to your husband about contraception, how easy would it be for you to talk to him?
very difficult 1.3 (3) 1.8 (4) 0.83 (0.59–1.17), 0.29
difficult 7.2 (17) 9.6 (22)
not sure 17.9 (42) 17.5 (40)
easy 51.5 (121) 52.8 (121)
very easy 22.1 (52) 18.3 (42)
If you wanted to use the pill, IUD, injection or implant, how certain are you that you could use it?
very certain I could not 1.3 (3) 0.9 (2) 1.19 (0.84–1.68), 0.33
certain I could not 4.7 (11) 4.4 (10)
not sure 43.4 (102) 39.7 (91)
certain I could 43.8 (103) 47.2 (108)
very certain I could 6.8 (16) 7.9 (18)
If you wanted to talk to your husband about contraception, how certain are you that you could talk to him?
very certain I could not – – 1.05 (0.73–1.50), 0.80
certain I could not 2.6 (6) 3.5 (8)
not sure 18.7 (44) 11.8 (27)
certain I could 53.6 (126) 63.3 (145)
very certain I could 25.1 (59) 21.4 (49)
I intend to use the pill, IUD, injection, implant or patch
strongly disagree 2.1 (5) 2.6 (6) 1.85 (1.29–2.65), 0.001
disagree 13.6 (32) 4.4 (10)
not sure 24.7 (58) 18.3 (42)
agree 51.1 (120) 63.8 (146)
strongly agree 8.5 (20) 10.9 (25)
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in the control group (Fisher’s exact test p = 0.45). Most
intervention participants who answered the question 'Did
anything good or bad happend as a result of receiving
the messages?' (193/229) said that they benefitted from
the messages, mainly from the increase in information
and awareness about the contraceptive methods. No par-
ticipants reported any serious negative events that hap-
pened during the study.
Sensitivity analyses
The effect of the intervention on the primary outcome
observed in the principal analysis (adjusted OR 2.34,
95% CI 1.48–3.68, p < 0.001) moved slightly towards the
null when we considered participants who were lost to
follow up did not find at least one method of effective
contraception acceptable (OR 2.13, 95% CI 1.37–3.30,
p = 0.001).
The strongest baseline predictor of retention was hav-
ing completed university. This was already adjusted for
in the primary analysis and the sensitivity analysis model
was the same as the primary analysis.
Subgroup analysis
The intervention was less effective among participants
who wanted to avoid pregnancy at baseline compared to
participants who did not (interaction test p = 0.02)
(Fig. 2).
Intervention delivery
After the trial commenced, there were two technical
problems with the local platform that resulted in partici-
pants not being sent the full intervention. Based on the
data available from the local platform, 40% of interven-
tion participants were sent 90% or more of the interven-
tion messages and 8% of intervention participants were
sent less than 70% of the messages.
Table 3 Process outcomes (Continued)
Control
N = 235, % (n)
Intervention
N = 229, % (n)
Proportional ORa
(95% CI), p value
Number of messages read
all 62.9 (144)
most 21.8 (50)
some 11.4 (26)
none 3.9 (9)
Proportion of intervention participants that stopped the intervention 3.9 (9)
IUD intrauterine device
aEstimated from ordered logistic regression
bMean difference
Fig. 2 Primary outcome by prespecified subgroups
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Discussion
Main results
The results of this trial demonstrated that the interven-
tion improved young women’s attitudes towards effective
contraception in Palestine. The trial results also suggest
that the intervention moderately improves knowledge
about effective contraception, perceived norms about
friends using effective contraception and intention to
use effective contraception. The subgroup analysis sug-
gests that that the intervention may be less effective
among women who want to avoid pregnancy at baseline.
Comparisons with other research
We identified 11 trials evaluating individual-level inter-
ventions delivered by mobile phone to improve
contraceptive-related outcomes [20–30], using search
terms from a previous Cochrane review [41]. Of the five
trials where knowledge of contraception was an outcome
[20, 23–25, 30], four showed a beneficial effect of the
intervention compared to the control [20, 23–25]. Both
trials where knowledge of contraception was the primary
outcome showed a beneficial effect [24, 25]. All trials in-
cluded a use-related outcome, however, only three
showed a beneficial effect [20–22]. The results of this
Palestine trial are in line with research that has found
mobile phone interventions can increase contraceptive
knowledge [20, 23–25]. Previous research has demon-
strated that interventions delivered by mobile phone can
improve contraceptive use [20–22]. This current trial
did not find evidence of a difference in use between the
groups, although this study did not have enough statis-
tical power for this outcome. This is the first trial that
we are aware of that has shown that a contraceptive
behavioral intervention delivered by mobile phone mes-
saging can increase intention to use effective contracep-
tion. A similar intervention was evaluated by a trial in
Tajikistan [42] and in Bolivia with young people (manu-
script in preparation). A post hoc change from baseline
to follow-up analysis of all participants in Tajikistan
demonstrated a large increase in acceptability [42].
Strengths and limitations
An important strength of this trial is that we recruited
to target and achieved greater than 80% follow-up for
the primary outcome. Our trial database and
randomization system concealed the allocation sequence
and achieved well-balanced groups overall. There was,
however, some imbalance in acceptability at baseline,
but this was adjusted for in the primary analysis and had
little effect on the results when not controlled for. The
sensitivity analysis confirmed that our results were ro-
bust to different missing data assumptions.
The main limitation of the trial is that the whole inter-
vention was not delivered to all participants due to
technical problems with the local platform, so our result
can only tell us the effect of partial receipt of the inter-
vention. Another limitation is that all outcomes were
self-reported, which meant that they are more likely to
be biased than if they were objectively measured. For
example, the self-reported primary outcome collected by
telephone by research staff may have meant that partici-
pants were more likely to report positive attitudes at fol-
low up compared to baseline where they provided data
by paper questionnaire. In addition, the scoring of the
primary outcome measure may have led to an underesti-
mation of the true acceptability of effective contracep-
tion. In scoring the measure, we thought it better to
avoid false positives; for a method of effective contracep-
tion to be acceptable, participants had to choose “agree”
or “strongly agree” to the positively worded stems and
“disagree” or “strongly disagree” to the negatively
worded stems. In other words, for participants to score
“acceptable” they must have unequivocally thought the
method acceptable. It is possible that an individual could
believe that a method had unwanted side effects but
would still use it because they felt that the benefit of
using it outweighed the risks (that is, an unintended
pregnancy is more unwanted than the perceived side
effect). While this does not have implications for the ef-
fect of the intervention relative to the control, it means
that in the sample overall, the true acceptability may
have been higher at baseline and at follow up.
Most participants were university educated. The in-
clusion of participants from a wider range of
socio-economic backgrounds would have improved
the generalizability of the results. Although sexual ac-
tivity before marriage is highly stigmatized in
Palestine, it is possible that some non-married partici-
pants were sexually active. In this case, while it is the
best available measure of sexual activity in this con-
text, marital status would not have been a reliable
proxy. While we did not record why participants
assessed for eligibility were ineligible or were eligible
but declined to participate, 91% of eligible women
assessed (582/643) were randomized.
Meaning and implications of the findings
The intervention effect estimated in this trial is likely to
be conservative due to the moderate level of potential
contamination and the fact that an estimated 60% of
intervention participants were not sent the full interven-
tion. Further analysis of the trial data and of the data
on the local platform could evaluate the dose of the
intervention on the outcomes.
The finding that the intervention may be less effective
among women who want to avoid pregnancy at baseline,
could relate to exposure to information about contracep-
tion. Women who want to avoid pregnancy at baseline
McCarthy et al. Trials          (2019) 20:228 Page 10 of 13
may already have formed positive attitudes towards the
effective methods. Indeed, the level of acceptability at
baseline was higher among participants wanting to avoid
pregnancy compared to those who wanted to become
pregnant, were unsure or were not married (12% versus
7%), reducing the potential for improvement.
Due to the nature of the intervention, participants
would have been aware of their treatment allocation. It
is possible that this awareness, along with the greater
number of intervention messages compared to control
messages could have contributed to the improvement of
attitudes towards effective contraception observed in the
intervention group rather than the content of the inter-
vention itself.
Most trial participants were recruited through PFPPA’s
services. This group may have had a higher level of
acceptability of effective contraception, compared to
people who were not in any way connected to or aware
of family planning services. However, the low baseline
acceptability in the trial sample (8%) suggests that ac-
ceptability is low in general in the West Bank. Accept-
ability among intervention participants remained
relatively low at 31%. Further analysis of the individual
scales that comprise the primary outcome measure and
qualitative work could help clarify why the intervention
did not improve acceptability to a greater extent.
Although not powered to detect differences in contra-
ceptive behavioral outcomes, the effect estimates of the
intervention for these outcomes (use of effective contra-
ception, unintended pregnancy and induced abortion),
while not statistically significant, were all in the direction
of intervention benefit. A larger trial powered for these
outcomes would provide a more precise estimate.
It is noteworthy that, although not statistically signifi-
cant, the odds of finding the contraceptive pill accept-
able in the intervention group relative to the control
group were lowest out of all the methods. Further ana-
lysis of the baseline data showed that a larger proportion
of participants at baseline knew what the pill was com-
pared to the other methods. Because there was greater
awareness of the pill in the study population at the out-
set, views on the method may have been less amenable
to the influence of the intervention. Participants may
have been less likely to have negative preconceived ideas
about the other methods as there was less awareness of
them. Further research could explore attitudes towards
the pill versus other methods in the Palestinian context.
The results indicate that implementation of the inter-
vention in Palestine could improve young women’s atti-
tudes towards effective contraceptive methods. If the
intervention could be delivered at low cost (e.g. though
a mobile phone app rather than through mobile phone
text message), its implementation would be justified and
research would be required to understand how the
implementation would work in a non-trial context. Im-
plementation of the intervention delivered by text mes-
sage, however, would require evidence that the
intervention can improve behavioral outcomes, due to
cost of sending text messages. If the intervention is
made available, the local platform will need regular
monitoring and maintenance to ensure that the inter-
vention is delivered as intended.
Conclusions
This trial demonstrated that the intervention more than
doubled the odds of finding at least one method of effect-
ive contraception acceptable. This result along with the
lack of evidence that it is associated with any harm, sup-
ports the implementation of the intervention in Palestine.
Future research is needed to evaluate the efficacy of the
intervention on use of effective contraception and unin-
tended pregnancy in Palestine and to determine how to
enable successful implementation.
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